Добро пожаловать
Нажатие «Авторизоваться» означает, что вы соглашаетесь с Условия использования и политика конфиденциальности Cointime.
Зарегистрировать аккаунт
Аккаунт уже существует?
Нажатие «page.Sign up» означает, что вы соглашаетесь с <a class="underline" href="#term-of-service">Условия использования</a> и a class="underline" href="#privacy-policy">политика конфиденциальности</a> Cointime.
Войдите, используя email
Зарегистрируйтесь с помощью email
твой почтовый ящик
Проверь свои входящие
Нажмите на ссылку в , чтобы войти.
Нажмите на ссылку в , чтобы зарегистрироваться.
DNAnexus
company
About
DNAnexus develops a cloud platform and global network designed for scientific collaboration and accelerated discovery.
- Mountain View,California,United States
- 101 - 250
- http://dnanexus.com
Details
- Last Funding Type
- Series H
- Last Funding Money Raised
- $200M
- Industries
- Bioinformatics,Biotechnology,Cloud Computing,Medical,Software
- Founded date
- Jan 1, 2009
- Number Of Employee
- 101 - 250
- Operating Status
- Active
- Legal Name
- DNAnexus, Inc.
DNAnexus develops a cloud platform and global network designed for scientific collaboration and accelerated discovery. It provides security, scalability, and collaboration for enterprises and organizations that are pursuing genomic-based approaches to health in order to accelerate medical discovery. DNAnexus is supporting customers around the world that are tackling some of the most challenging and exciting opportunities in human health.The company was founded in 2009 and is based in Mountain View, California.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
9
$472.55M
DNAnexus has raised a total of
$472.55M
in funding over 2 rounds. Their latest funding was raised on
Mar 8, 2022 from a Series H round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Mar 8, 2022 | Series H | $200M | 6 |
Blackstone Accelerates Growth
|
— | Detail |
| Jun 9, 2020 | Series G | $100M | 7 |
Perceptive Advisors
|
— | Detail |
| Feb 6, 2019 | Series F | $68M | 6 | — | — | Detail |
| Jan 2, 2018 | Series E | $58M | 7 |
|
— | Detail |
| May 1, 2017 | Debt Financing | — | — | — | — | Detail |
Investors
Number of Lead Investors
Number of Investors
12
18
DNAnexus is funded by 18 investors.
Blackstone Accelerates Growth
and WuXi AppTec
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
|
Blackstone Accelerates Growth
|
Yes | Series H |
WuXi AppTec
|
Yes | Series D |
|
|
— | Series H |
GV
|
— | Series H |
Innovatus Capital Partners
|
— | Series H |
|
|
— | Series H |
|
Perceptive Advisors
|
— | Series H |
First Round Capital
|
— | Series G |
Regeneron
|
— | Series G |
TPG Biotech
|
— | Series G |
Employee Profiles
Number of Employee Profiles
38
DNAnexus has 38 current employee profiles, including
Executive George Asimenos
Executive
Executive
Advisor
Advisor
Executive
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
